419 related articles for article (PubMed ID: 33281050)
1. Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series.
Abolmaali M; Heidari M; Zeinali M; Moghaddam P; Ramezani Ghamsari M; Jamshidi Makiani M; Mirzaasgari Z
J Clin Neurosci; 2021 Jan; 83():119-122. PubMed ID: 33281050
[TBL] [Abstract][Full Text] [Related]
2. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 associated Guillain-Barré syndrome.
Pelea T; Reuter U; Schmidt C; Laubinger R; Siegmund R; Walther BW
J Neurol; 2021 Apr; 268(4):1191-1194. PubMed ID: 32770414
[TBL] [Abstract][Full Text] [Related]
4. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
Juliao Caamaño DS; Alonso Beato R
J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?
Khan F; Sharma P; Pandey S; Sharma D; V V; Kumar N; Shukla S; Dandu H; Jain A; Garg RK; Malhotra HS
J Med Virol; 2021 Oct; 93(10):6045-6049. PubMed ID: 34170552
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
Chan JL; Ebadi H; Sarna JR
Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
[No Abstract] [Full Text] [Related]
9. Guillain-Barré syndrome associated with COVID-19 infection.
Manji HK; George U; Mkopi NP; Manji KP
Pan Afr Med J; 2020; 35(Suppl 2):118. PubMed ID: 33282073
[TBL] [Abstract][Full Text] [Related]
10. A Case of Guillain-Barré Syndrome Associated With COVID-19.
Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
[TBL] [Abstract][Full Text] [Related]
13. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
[TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
[TBL] [Abstract][Full Text] [Related]
18. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
Front Immunol; 2022; 13():894872. PubMed ID: 35924236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
